Amsterdam UMC, location VUmc
amsterdamumc.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
300
Active
67
Phase 3
18
Total enrollment
100,457
Pipeline matrix
Showing 22 of 22 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| ertugliflozine | — | — | — | — | — | 1 | |
| Ocrelizumab | — | — | — | — | — | 1 | |
| Sotatercept | — | — | — | — | — | 1 | |
| Macrogol Only Product in Oral Dose Form | — | — | — | — | — | 1 | |
| Magnesium hydroxide 724mg | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | 2 | ||
| Rituximab | — | — | — | — | — | 1 | |
| Neoadjuvant systemic therapy | — | — | — | — | — | 1 | |
| Gemcitabine, Cisplatin | — | — | — | — | — | 1 | |
| Celecoxib 400mg | — | — | — | — | — | 1 | |
| repetitive transcranial magnetic stimulation | — | — | — | — | — | 1 | |
| Folfirinox | — | — | — | — | — | 1 | |
| Iberdomide plus low-dose cyclophosphamide and dexamethasone | — | — | — | — | — | 1 | |
| Metformin | — | — | — | — | — | 1 | |
| Group 1 - Intradermal ipilimumab | — | — | — | — | — | 1 | |
| Group 2 - Conventional treatment | — | — | — | — | — | 1 | |
| Inotropes | — | — | — | — | — | 1 | |
| FES | — | — | — | — | — | 1 | |
| Systematic multidisciplinary medication review + ACP | — | — | — | — | — | 1 | |
| [18F]F-AraG PET imaging | — | — | — | — | — | 1 | |
| [89Zr]Zr-Df-Crefmirlimab PET imaging | — | — | — | — | — | 1 | |
| Intrathecal Baclofen Pump | — | — | — | — | — | 1 |
Next readouts
- 2025-12
- 2025-12
- 2025-12-01
- 2026-05-01
- 2026-07
- 2026-12
- 2026-12
- 2027-02
- 2027-05
- 2027-05-01
Top conditions
- Multiple Sclerosis11
- Coronary Artery Disease7
- Breast Cancer7
- Type 2 Diabetes6
- Obesity6
- Colorectal Cancer6
- Diabetes Mellitus, Type 26
- Diabetes Mellitus5
Frequently asked questions about Amsterdam UMC, location VUmc
- How many clinical trials does Amsterdam UMC, location VUmc have on ClinicalTrials.gov?
- Amsterdam UMC, location VUmc is listed as the lead sponsor on 300 clinical trials in ClinicalTrials.gov, 67 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Amsterdam UMC, location VUmc's trials are in Phase 3?
- 18 of Amsterdam UMC, location VUmc's trials are in Phase 3, spread across 22 active drug programs.
- What therapeutic areas does Amsterdam UMC, location VUmc focus on?
- Amsterdam UMC, location VUmc's most-studied conditions on ClinicalTrials.gov are Multiple Sclerosis, Coronary Artery Disease, Breast Cancer, Type 2 Diabetes, Obesity.
- When are Amsterdam UMC, location VUmc's next clinical trial readouts?
- Amsterdam UMC, location VUmc has 10 upcoming primary-completion readouts tracked here; the soonest is “DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes”, expected around 2025-12.